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Abstract
Background: The hypertriglyceridemic waist (HW) phenotype has been shown to be strongly associated with
metabolic abnormalities; however, to date, no study has reported the prediction of metabolic abnormalities using
the HW phenotype along with waist circumference (WC) and the triglyceride (TG) level or various phenotypes
consisting of an individual anthropometric index combined with the TG level. The objectives of this study were to
assess the association of the HW phenotype with metabolic abnormalities in Korean women and to evaluate the
predictive powers of various phenotypes with regard to metabolic abnormalities.
Methods: Total cholesterol (TC), high- and low-density lipoprotein (HDL and LDL) cholesterol, and TG levels, systolic
and diastolic blood pressures (SBP and DBP), and anthropometric indices were measured in 7661 women. The
Naive Bayes algorithm and logistic regression were used to determine the predictive powers of the models using
different phenotypes.
Results: The HW phenotype demonstrated the strongest association with all metabolic components. The best
phenotypic predictors were the forehead-to-rib circumference ratio + TG for the HDL level, age + TG for the LDL
level, age + TG for SBP, and rib circumference + TG and neck circumference + TG for DBP. The associations between
TG and TC or HDL were higher compared with those between WC and TC or HDL, whereas the associations
between WC and SBP or DBP were higher compared with those between TG and SBP or DBP. Age was strongly
associated with hypercholesterolemia, the HDL and LDL cholesterol levels, and SBP and had good predictive power,
but not with respect to DBP.
Conclusions: We have determined that the HW phenotype is a useful indicator of metabolic abnormalities in
Korean women; although HW had the strongest association with metabolic abnormalities, the best phenotype
combination consisting of a single anthropometric index and the TG level may differ depending on the metabolic
factors in question. Our findings provide insights into the detection of metabolic abnormalities in complementary
and alternative medicine.
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Background
In recent years, there have been many attempts to deter-
mine the clinical importance of the hypertriglyceridemic
waist (HW) phenotype in various diseases, such as car-
diovascular diseases (CVDs) and metabolic abnormal-
ities, because there is a critical need for convenient, easy
and cost-effective tools to evaluate risk factors for these
conditions [1]. The HW phenotype has been defined as
a combination of enlarged waist circumference (WC)
and a high plasma triglyceride (TG) level. Previous stud-
ies have indicated that the HW phenotype is closely as-
sociated with metabolic abnormalities [1–15], diabetes
mellitus [3, 7, 9, 16–24], CVD [5, 6, 8, 9, 14, 25–32], and
chronic kidney disease [33]. Furthermore, accumulating
evidence suggests that this phenotype is a useful indica-
tor of several diseases.
Numerous studies have demonstrated that the HW
phenotype is strongly associated with components of
metabolic abnormalities and is a strong indicator of
these abnormalities [1–15]. For example, Arsenault et al.
[2] found that subjects with the HW phenotype had
smaller low-density lipoprotein (LDL) particles, higher
blood pressure, lower levels of apolipoprotein A-I and
high-density lipoprotein (HDL) cholesterol, and higher
levels of apolipoprotein B and C-reactive protein com-
pared with subjects with a normal WC and TG level.
Amini et al. [3] found that men with the HW phenotype
had higher TG and cholesterol levels and a lower HDL
level compared with men without HW or with a high
WC or elevated TG level. They also found that women
with HW had higher fasting blood sugar, 2 h-post pran-
dial blood sugar, hemoglobin, TG, cholesterol, and LDL
levels and a lower HDL level compared with women
without HW or with a high WC or elevated TG level.
Esmaillzadeh et al. [4] indicated that adolescents with
HW had a strong tendency to have risk factors for
hypercholesterolemia and high LDL cholesterol and low
HDL cholesterol levels and that HW was a stronger pre-
dictor compared with the TG level, WC, and weight.
Hiura et al. [5] reported that HW was associated with
higher total cholesterol (TC), LDL, and TG levels and an
increased TC-to-HDL ratio and that WC alone could
not predict CVD risk. Alavian et al. [1] suggested that
HW was a useful indicator of metabolic risk in children
and was suitable for population-based studies. de Graaf
et al. [6] examined the utility of HW for the identifica-
tion of coronary artery disease evaluated by computed
tomographic coronary angiography (CTA) in men and
women with type-2 diabetes; these authors determined
that HW was strongly associated with the inflammatory
profile, TG, TC, HDL and LDL cholesterol levels, and
coronary artery disease. Yu et al. [7] suggested the fol-
lowing cutoff values for HW to predict type-2 diabetes
in Chinese adults: WC ≥ 75 cm and TG ≥ 110 mg/dl.
Czernichow et al. [8] concluded from a 7.5-year longitu-
dinal study that HW was a good predictor of CVD in
middle-aged French men. StPierre et al. [9] documented
that Canadian men and women with type-2 diabetes and
HW exhibited their first CVD manifestations 5 years
earlier compared with individuals without HW; further-
more, they reported that HW was an important pre-
dictor of CVD symptoms.
These studies have suggested that the HW phenotype
is a risk factor for metabolic abnormalities and that this
phenotype can be used as a primary screening tool for
public health; however, to date, no study has compared
the predictive powers of the HW phenotype combined
with the TG level and WC and phenotypic combinations
of individual anthropometric indices with the TG level
for the identification of metabolic abnormalities. The ob-
jectives of this study were to assess the associations of
the HW phenotype with metabolic factors, such as the
TC, HDL and LDL levels, and systolic and diastolic
blood pressures (SBP and DBP, respectively) in Korean
women and to evaluate the powers of the HW pheno-
type combined with the TG level and WC and of various
phenotypes consisting of single anthropometric indices
and the TG level to predict metabolic abnormalities. The
evaluations of all predictive models were based on two
machine-learning algorithms. Additionally, this study
aimed to compare whether phenotypes consisting of sin-
gle indices and the TG level were better in terms of the
ability to predict metabolic abnormalities. This study
may aid in the development of decision support systems
for the initial screening of metabolic abnormalities in
women. To our knowledge, this is the first study evaluat-
ing the predictive powers of phenotypes consisting of
the TG level and single anthropometric indices to iden-
tify individuals with metabolic abnormalities.
Methods
Participants
The data used in this retrospective cross sectional study
were provided by the Korean Health and Genome Epi-
demiology Study database (KHGES). All participants
were recruited from hospitals in Anseong, Ansan, and
other cities in the Republic of Korea between November
2006 and August 2013. A total of 7661 Korean women
aged 20–85 years participated in this study. The Korea
Institute of Oriental Medicine (KIOM) Institutional Re-
view Board approved the study, and written informed
consent was obtained from all participants.
Measurements and data collection
We collected subjects’ demographic and clinical charac-
teristics from self-reported data. TC, HDL, LDL, SBP,
and DBP levels were measured for all participants by
trained clinicians based on standardized protocols
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(ADVIA1800, Siemens, USA), and all participants were
required to fast for at least 8 h prior to testing. BP was
measured manually from the left upper arm after a suffi-
cient period of rest using a standard sphygmomanometer.
Anthropometric indices were estimated by trained ob-
servers or clinicians using standard operating proce-
dures. Height and weight were measured to the nearest
0.1 cm and 0.1 kg, respectively, for subjects who wore
lightweight clothing without shoes (LG-150; G Tech
International Co., Ltd., Uijeongbu, Republic of Korea).
The circumferences of the forehead, neck, axilla, chest,
rib, waist, pelvis, and hip were estimated using non-
elastic tape. We then computed ratio indices, such as
the waist-to-hip ratio (WHR) and body mass index
(BMI), which are widely used in medicine [34, 35]. De-
tailed information on the measurement positions and
protocols for humans has been described in several pre-
vious studies [34–37]. In brief, forehead circumference
(ForeheadC) was gauged at the levels of the glabella and
occiput of the head. Neck (NeckC) and axillary circum-
ferences (AxillaryC) were measured at the levels of the
thyroid cartilage and cricoid cartilage and at the levels of
the left and right axillae, respectively. Chest (ChestC)
and rib circumferences (RibC) were measured at the
levels of the left and right nipples and at the levels of the
left and right 7th and 8th prominences of the costochon-
dral junction, respectively. Waist circumference (WaistC,
WC) was gauged at the level of the umbilicus. Further,
pelvic (PelvicC) and hip circumferences (HipC) were
measured at the levels of the left and right anterior su-
perior iliac spines and at the level of the upper edge of
the pubis, respectively [34–37].
The inclusion criteria of the subjects were as follows:
1) submission of written informed consent; 2) women
aged 20-85 years; and 3) Koreans residing in the Repub-
lic of Korea. The exclusion criteria were as follows: 1)
omission of blood information; and 2) omission of an-
thropometric measurements.
Definitions
The diagnosis of metabolic abnormalities was based on
the recommendations of the National Cholesterol Edu-
cation Program Adult Treatment Panel III (NCEP-ATP
III) [38]. Hypercholesterolemia was defined as TC ≥
240 mg/dL; hypo-HDL cholesterolemia was defined as
HDL < 50 mg/dL; and hyper-LDL cholesterolemia was
defined as LDL ≥ 160 mg/dL. Hypertension was defined
as SBP ≥ 130 mmHg and/or DBP ≥ 85 mmHg. The HW
phenotype was defined as WC ≥ 85 cm and TG ≥
1.5 mmol/L (133 mg/dl), in accordance with the criteria
used for women in previous studies [2, 30, 32, 39].
Table 1 lists all features related to the metabolic factors
and anthropometric indices used in this study.
Statistical analysis
Statistical analyses were performed with SPSS 19 for
Windows (SPSS Inc., Chicago, IL, USA). Crude and age-
and site-adjusted analyses were conducted using binary
logistic regression (LR) to test for differences between
the subjects with metabolic abnormalities and normal
subjects regarding the HW phenotype and each individ-
ual index after standardization (odds ratios (ORs) and
95 % confidence intervals [CIs]). All predictive analyses
were performed using the Waikato Environment for
Knowledge Analysis (WEKA) data mining tool. For a
more reliable prediction of metabolic abnormalities, two
machine-learning algorithms, the Naïve Bayes algorithm
(NB) and LR, were used to determine the predictive
powers of all phenotypes, using combinations of
Table 1 All features related to metabolic components and
anthropometric indices in Korean women (Std.: standard
deviation)
Variable Mean (Std.) Description
Subjects 7661 Number of female subjects
HW subjects 1484 Number of subjects with the
HW phenotype
TC (mg/dL) 192.1 (34.78) Total cholesterol
HDL (mg/dL) 50.65 (13.36) High-density lipoprotein cholesterol
LDL (mg/dL) 116.1 (32.26) Low-density lipoprotein cholesterol
TG 121.2 (73.04) Triglycerides
SBP (mmHg) 118.6 (16.74) Systolic blood pressure
DBP (mmHg) 76.64 (10.67) Diastolic blood pressure
Height 155.9 (6.17) Height
Weight 57.82 (8.435) Weight
BMI 23.81 (3.358) Body mass index
Age 53.03 (13.76) Age
NeckC 33.28 (2.214) Neck circumference
ChestC 90.47 (8.017) Chest circumference
RibC 79.64 (8.263) Rib circumference
WaistC (WC) 83.99 (9.306) Waist circumference
HipC 92.95 (6.049) Hip circumference
Neck_Hip 0.359 (0.022) Neck-to-hip circumference ratio
Axillary_Hip 0.945 (0.047) Axillary-to-hip circumference ratio
Chest_Hip 0.973 (0.06) Chest-to-hip circumference ratio
Rib_Hip 0.856 (0.064) Rib-to-hip circumference ratio
Waist_Hip (WHR) 0.903 (0.072) Waist-to-hip circumference ratio
Pelvic_Hip 0.973 (0.042) Pelvic-to-hip circumference ratio
Forehead_Waist 0.662 (0.073) Forehead-to-waist circumference ratio
Neck_Waist 0.399 (0.034) Neck-to-waist circumference ratio
Forehead_Rib 0.697 (0.071) Forehead-to-rib circumference ratio
Forehead_Chest 0.612 (0.053) Forehead-to-chest circumference ratio
WHtR 0.371 (0.051) Waist-to-height circumference ratio
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individual anthropometric indices and the TG level, for
the diagnosis of metabolic abnormalities. In brief, in ac-
cordance with previous studies [37, 40, 41], for a given
feature (x) and label y in NB, a joint probability is esti-
mated from the training data. Hence, it is a generative
model. In contrast, LR estimates the probability(y/x) dir-
ectly from the training data by minimizing error. Hence,
it is a discriminative model. In addition, NB assumes
that all features are conditionally independent. Thus, if
some of the features are dependent on each other in the
case of a large feature space, the predictive power might
be low, but the LR model may work well, even if some
of the variables are correlated [37, 40, 41]. We used the
area under the receiver operating characteristic curve
(AUC) to evaluate the predictive powers of all models. All
predictions were tested using 10-fold cross-validation.
Furthermore, for comparison of AUCs between a single
anthropometric index and phenotype, we used the non-
parametric test suggested by Delong et al. [42].
Results
Out of a total of 7661 subjects, 1961 had metabolic syn-
drome (MS) according to the criteria for MS recom-
mended by the NCEP-ATP III. With regard to each
metabolic abnormality, 1258 women with the HW
phenotype were in the non-hypercholesterolemia group
(n = 6973), and 226 were in the hypercholesterolemia
group (n = 688). In addition, 311 women with the HW
phenotype were in the non-hypo-HDL cholesterolemia
group (n = 3654), and 1173 were in the hypo-HDL cho-
lesterolemia group (n = 4007). Further, 1268 women with
the HW phenotype were in the non-hyper-LDL choles-
terolemia group (n = 6918), and 216 were in the hyper-
LDL cholesterolemia group (n = 743). A total of 1182
women with the HW phenotype were in the normal SBP
group (n = 6756), and 302 were in the high SBP group
(n = 905). Finally, 1163 women with the HW phenotype
were in the normal DBP group (n = 6644), and 321 were
in the high DBP group (n = 1017).
TC
Table 2 lists the results of the association between the
TC level and HW phenotype and the predictive powers
of the models using each index/TG combination to
identify hypercholesterolemia. The HW phenotype
showed the strongest association with hypercholesterol-
emia, even after adjusting for site and age (p < 0.0001,
OR = 2.222 [95 % CI 1.874-2.635]), adjusted OR = 1.875
[1.567-2.243]). Age (p < 0.0001, OR = 1.568 [1.439-1.708],
AUC by NB = 0.648, AUC by LR = 0.62) and TG (p <
0.0001, OR = 1.528 [1.436-1.626], adjusted OR = 1.452
[1.362-1.549], AUC by NB = 0.647, AUC by LR = 0.686)
were the most strongly associated with hypercholesterol-
emia and were strong predictors of hypercholesterolemia
after the HW phenotype. A comparison of WC and the
TG level as HW phenotype components revealed that
the association of TG with hypercholesterolemia was
higher compared with that of WC with hypercholester-
olemia and that TG had greater predictive power com-
pared with WC. Among the combinations of single
variables and TG, the age + TG phenotype was the best
predictor of hypercholesterolemia according to the NB
results (AUC by NB = 0.699); however, NeckC + TG was
the best predictor according to the LR results (AUC by
LR = 0.686).
HDL and LDL
Tables 3 and 4 show the associations of the HW pheno-
type with the HDL and LDL levels, as well as the powers
of the models of all phenotypes consisting of an individ-
ual index and the TG level, to predict hypo-HDL choles-
terolemia and hyper-LDL cholesterolemia. The HW
phenotype was the most strongly associated with the
HDL level (p < 0.0001, OR = 4.449 [3.889-5.09], adjusted
OR = 3.646 [3.157-4.21]). The TG level showed the
strongest association with the HDL level after the HW
phenotype (p < 0.0001, OR = 2.787 [2.59-2.999], adjusted
OR = 2.612 [2.415-2.825]). Among the anthropometric
indices, RibC was the most strongly associated with
HDL, after adjustments for site and age. The TG level
(p < 0.0001, OR = 2.787 [2.59-2.999], adjusted OR = 2.612
[2.415-2.825]) was more strongly associated with the
HDL level than with WC (p < 0.0001, OR = 1.737 [1.653-
1.826], adjusted OR = 1.515 [1.432-1.602]). The Forehea-
d_Rib + TG phenotype was the strongest predictor of
HDL (AUC by NB = 0.722, AUC by LR = 0.73).
The HW phenotype was the most strongly associated
with the LDL level compared with the other single indi-
ces (p < 0.0001, OR = 1.826 [1.541-2.164], adjusted OR =
1.459 [1.222-1.741]); however, this phenotype was less
strongly associated with the LDL level compared with
the TC and HDL levels, SBP, and DBP. Regarding WC
and the TG level, the association between the TG level
and the LDL level (p < 0.0001, OR = 1.324 [1.246-1.406],
adjusted OR = 1.236 [1.159-1.318]) was similar to that
between WC and the LDL level (p < 0.0001, OR = 1.397
[1.297-1.505], adjusted OR = 1.242 [1.142-1.35]). Among
all phenotypes, the age + TG phenotype was the stron-
gest predictor of the LDL level (AUC by NB = 0.662,
AUC by LR = 0.65).
SBP and DBP
Tables 5 and 6 list the experimental results for the asso-
ciations of the HW phenotype with SBP and DBP, as
well as the powers of the models of all index/TG
combinations to predict hypertension. The HW phenotype
had the strongest association with SBP among all variables
(p < 0.0001, OR = 2.362 [2.029-2.749], adjusted OR = 1.646
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[1.397-1.938]). Among all single indices, age was the most
strongly associated with SBP (p < 0.0001, OR = 2.345
[2.152-2.555]) after HW and was the best predictor of
SBP (AUC = 0.707). WC (p < 0.0001, OR = 1.677
[1.564-1.797], adjusted OR = 1.334 [1.233-1.444]) was
more strongly associated with SBP than with the TG
level (p < 0.0001, OR = 1.377 [1.3-1.459], adjusted OR =
1.24 [1.165-1.321]). WC (AUC = 0.653) was also a stronger
predictor than the TG level (AUC by NB = 0.62, AUC by
LR = 0.631). Age + TG was the best predictor of SBP status
(AUC by NB = 0.713, AUC by LR = 0.718).
The HW phenotype was the most strongly associated
with DBP compared with all variables, and after adjust-
ments for site and age, this association remained the
strongest (p < 0.0001, OR = 2.174 [1.877-2.517], adjusted
OR = 1.946 [1.664-2.276]). WC was more strongly asso-
ciated with DBP (p < 0.0001, OR = 1.546 [1.448-1.651],
adjusted OR = 1.459 [1.355-1.57]) than with the TG level
(p < 0.0001, OR = 1.276 [1.207-1.35], adjusted OR = 1.236
[1.164-1.313]), and WC (AUC = 0.629) was a stronger
predictor than the TG level (AUC by NB = 0.585, AUC
by LR = 0.591). Among the phenotypes, RibC + TG
(AUC by NB = 0.638, AUC by LR = 0.642) and NeckC +
TG (AUC by NB = 0.638, AUC by LR = 0.64) were the
strongest indicators of DBP status; however, the addition
of the TG level to WC added very little predictive
power.
Discussion
This study, which was conducted on a population of
Korean women, has identified a strong association be-
tween the HW phenotype and metabolic abnormalities.
Furthermore, the results have shown that the best pheno-
type for identifying metabolic abnormalities may differ ac-
cording to the metabolic factor of interest.
Many studies have indicated that the HW phenotype
is closely associated with metabolic abnormalities, and it
is a simple, inexpensive and accurate predictor of these
abnormalities [1–16, 23, 27, 30, 38]. For example,
Lemieux et al. [11] indicated that the combination of
WC and the TG level constitutes a simple and inexpen-
sive indicator of the risk of atherogenic metabolic
Table 2 Analysis of the associations and powers of models of the HW phenotype and all phenotypes consisting of an individual
index with/without the TG level to predict hypercholesterolemia
Variable Crude Adjustment AUC Phenotype AUC
p OR (95 % CI) p OR (95 % CI) NB LR NB LR
HW phenotypea <0.0001 2.222 (1.874–2.635) <0.0001 1.875 (1.567–2.243)
TG <0.0001 1.528 (1.436–1.626) <0.0001 1.452 (1.362–1.549) 0.647 0.686
Age <0.0001 1.568 (1.439–1.708) 0.648 0.62 Age + TG 0.699 0.681***
Weight 0.0001 1.169 (1.084–1.261) 0.0001 1.177 (1.088–1.273) 0.551 0.552 Weight + TG 0.646 0.682***
BMI <0.0001 1.28 (1.188–1.379) 0.0002 1.166 (1.074–1.265) 0.582 0.583 BMI + TG 0.652 0.679***
NeckC 0.0146 1.1 (1.019–1.187) 0.0143 1.109 (1.021–1.206) 0.53 0.531 NeckC + TG 0.638 0.686***
ChestC <0.0001 1.288 (1.193–1.39) <0.0001 1.23 (1.13–1.338) 0.576 0.578 ChestC + TG 0.644 0.677***
RibC <0.0001 1.263 (1.171–1.362) 0.0004 1.172 (1.074–1.279) 0.574 0.575 RibC + TG 0.649 0.679***
WaistC (WC) <0.0001 1.279 (1.184–1.381) 0.0011 1.156 (1.06–1.262) 0.574 0.575 WaistC + TG 0.647 0.679***
HipC 0.0207 1.095 (1.014–1.182) 0.0264 1.096 (1.011–1.188) 0.524 0.527 HipC + TG 0.648 0.684***
Neck_Hip 0.8888 1.006 (0.93–1.087) 0.8403 1.009 (0.927–1.097) 0.485 0.467 Neck_Hip + TG 0.64 0.684***
Axillary_Hip <0.0001 1.219 (1.128–1.316) 0.0001 1.186 (1.091–1.289) 0.554 0.557 Axillary_Hip + TG 0.635 0.676***
Chest_Hip <0.0001 1.313 (1.216–1.419) <0.0001 1.225 (1.123–1.336) 0.582 0.583 Chest_Hip + TG 0.642 0.675***
Rib_Hip <0.0001 1.288 (1.192–1.391) 0.0020 1.161 (1.056–1.277) 0.573 0.576 Rib_Hip + TG 0.643 0.677***
Waist_Hip (WHR) <0.0001 1.319 (1.22–1.426) 0.0046 1.145 (1.043–1.258) 0.578 0.582 Waist_Hip + TG 0.643 0.676***
Pelvic_Hip <0.0001 1.328 (1.225–1.439) 0.0608 1.093 (0.996–1.2) 0.578 0.58 Pelvic_Hip + TG 0.644 0.676***
Forehead_Waist <0.0001 0.736 (0.678–0.8) 0.0006 0.846 (0.768–0.931) 0.586 0.584 Forehead_Waist + TG 0.649 0.675***
Neck_Waist <0.0001 0.759 (0.699–0.824) 0.0085 0.885 (0.808–0.969) 0.574 0.576 Neck_Waist + TG 0.648 0.677***
Forehead_Rib <0.0001 0.742 (0.685–0.805) 0.0002 0.832 (0.755–0.916) 0.588 0.584 Forehead_Rib + TG 0.651 0.675***
Forehead_Chest <0.0001 0.733 (0.676–0.795) <0.0001 0.803 (0.733–0.88) 0.587 0.588 Forehead_Chest + TG 0.649 0.675***
WHtR <0.0001 1.233 (1.144–1.329) 0.0001 1.177 (1.087–1.274) 0.569 0.57 WHtR + TG 0.648 0.68***
Adjustments for age and site (investigation site), OR odds ratio, CI confidence interval, AUC area under the receiver operating characteristic curve, NB Naïve Bayes,
LR logistic regression
Significant difference between a single anthropometric index and phenotype on AUCs determined by LR, *** p = <0.00001
a There were 1258 women with the HW phenotype in the non-hypercholesterolemia group (n = 6973) and 226 in the hypercholesterolemia group (n = 688)
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abnormalities and CAD in Canadian men. Irving et al.
[14] reported that compared with women with MS but
without HW, those with both MS and HW tended to
have a lower total HDL cholesterol level and higher ab-
dominal visceral fat mass and insulin, TC, non-HDL
cholesterol, and VLDL cholesterol levels. They argued
that in obese women with MS and HW, the HW aggra-
vates cardiometabolic abnormalities and insulin resist-
ance. Esmaillzadeh et al. [4] proposed HW as a simple
and efficient predictor of metabolic abnormalities and
MS in adolescents. Additionally, Zhang et al. [43] found
that in Chinese men and women, HW and the visceral
adiposity index score (defined by the HDL cholesterol
and TG levels, WC, and BMI) were strongly associated
with coronary heart disease. These authors suggested
that HW was an indicator of the risk of coronary heart
disease in Asian individuals of normal weight with vis-
ceral adiposity. de Graaf et al. [6] indicated that individ-
uals with type-2 diabetes and HW tended to have an
increased risk of coronary artery disease and abnormal
blood lipid profiles compared with those without HW
and that HW was a practical clinical indicator of coron-
ary artery disease risk in subjects with type-2 diabetes.
Hiura et al. [5] tested the utility of HW as a predictor of
CVD risk in indigenous Australian women and found
that HW was associated with an elevated TC-to-HDL
ratio and higher TC, LDL, and TG levels. These authors
also suggested that HW was a good indicator of high
plasma insulin and apolipoprotein B levels and thus, of
cardiovascular risk. Amini et al. [3] reported that HW
was associated with diabetes in men and women and
with impaired glucose tolerance in women. Our findings
are in support of those of previous studies. We found
that among the anthropometric indices, HW was the
most strongly associated with the TC, HDL, and LDL
levels, SBP, and DBP.
Several studies have demonstrated the superiority of
the HW phenotype for detecting metabolic abnormal-
ities in terms of its simplicity, cost-effectiveness, and dis-
criminatory ability compared with the NCEP-ATP III
Table 3 Analysis of the associations and powers of models of the HW phenotype and all phenotypes consisting of an individual
index with/without the TG level to predict hypo-HDL cholesterolemia
Variable Crude Adjustment AUC Phenotype AUC
p OR (95 % CI) p OR (95 % CI) NB LR NB LR
HW phenotypea <0.0001 4.449 (3.889–5.09) <0.0001 3.646 (3.157–4.21)
TG <0.0001 2.787 (2.59–2.999) <0.0001 2.612 (2.415–2.825) 0.679 0.71
Age <0.0001 1.729 (1.646–1.815) 0.649 0.649 Age + TG 0.712 0.724***
Weight <0.0001 1.33 (1.27–1.394) <0.0001 1.396 (1.327–1.469) 0.583 0.583 Weight + TG 0.69 0.714***
BMI <0.0001 1.634 (1.555–1.717) <0.0001 1.466 (1.389–1.547) 0.64 0.64 BMI + TG 0.708 0.722***
NeckC <0.0001 1.579 (1.503–1.659) <0.0001 1.576 (1.492–1.665) 0.624 0.624 NeckC + TG 0.701 0.721***
ChestC <0.0001 1.738 (1.654–1.827) <0.0001 1.529 (1.447–1.614) 0.654 0.654 ChestC + TG 0.714 0.726***
RibC <0.0001 1.84 (1.749–1.937) <0.0001 1.603 (1.514–1.699) 0.669 0.669 RibC + TG 0.719 0.729***
WaistC (WC) <0.0001 1.737 (1.653–1.826) <0.0001 1.515 (1.432–1.602) 0.652 0.652 WaistC + TG 0.712 0.725***
HipC <0.0001 1.279 (1.221–1.339) <0.0001 1.336 (1.269–1.407) 0.564 0.565 HipC + TG 0.687 0.713***
Neck_Hip <0.0001 1.242 (1.185–1.3) <0.0001 1.169 (1.11–1.231) 0.561 0.562 Neck_Hip + TG 0.683 0.712***
Axillary_Hip <0.0001 1.393 (1.329–1.46) <0.0001 1.201 (1.14–1.264) 0.597 0.597 Axillary_Hip + TG 0.69 0.714***
Chest_Hip <0.0001 1.692 (1.611–1.778) <0.0001 1.341 (1.269–1.417) 0.646 0.646 Chest_Hip + TG 0.71 0.725***
Rib_Hip <0.0001 1.844 (1.753–1.941) <0.0001 1.502 (1.413–1.597) 0.667 0.668 Rib_Hip + TG 0.718 0.729***
Waist_Hip (WHR) <0.0001 1.762 (1.676–1.852) <0.0001 1.423 (1.34–1.51) 0.652 0.652 Waist_Hip + TG 0.711 0.725***
Pelvic_Hip <0.0001 1.571 (1.496–1.649) <0.0001 1.204 (1.136–1.275) 0.628 0.628 Pelvic_Hip + TG 0.703 0.72***
Forehead_Waist <0.0001 0.561 (0.533–0.589) <0.0001 0.674 (0.636–0.714) 0.657 0.657 Forehead_Waist + TG 0.714 0.726***
Neck_Waist <0.0001 0.703 (0.671-0.737) <0.0001 0.851 (0.807-0.898) 0.6 0.6 Neck_Waist + TG 0.695 0.716***
Forehead_Rib <0.0001 0.526 (0.5-0.554) <0.0001 0.634 (0.597-0.672) 0.673 0.673 Forehead_Rib + TG 0.722 0.73***
Forehead_Chest <0.0001 0.556 (0.529-0.585) <0.0001 0.678 (0.641-0.716) 0.66 0.66 Forehead_Chest + TG 0.718 0.727***
WHtR <0.0001 1.493 (1.422-1.566) <0.0001 1.439 (1.366-1.515) 0.616 0.616 WHtR + TG 0.699 0.718***
Adjustments for age and site (investigation site), OR odds ratio, CI confidence interval, AUC area under the receiver operating characteristic curve, NB naïve Bayes,
LR logistic regression
Significant difference between a single anthropometric index and phenotype on AUCs determined by LR, *** p = <0.00001
a There were 311 women with the HW phenotype in the non-hypo-HDL cholesterolemia group (n = 3654) and 1173 in the hypo-HDL cholesterolemia
group (n = 4007)
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and International Diabetes Federation (IDF) criteria. For
example, Zainuddin et al. [15] examined the concord-
ance of the IDF and NCEP-ATP III criteria and HW in
evaluating the prevalence of MS in Malaysian men and
women and argued that because the three criteria were
sufficiently concordant, HW should be used as a primary
screening tool to detect MS in developing countries.
Blackburn et al. [13] compared the abilities of HW and
the NCEP-ATP III and IDF criteria to identify subjects
with cardiometabolic risk factors and suggested that
HW might have a similar discriminatory power and that
it could be used as the primary screening tool to detect
subjects at higher risk of cardiometabolic disease. In a
Spanish population, Gomez-Huelgas et al. [12] also
found that the prevalence of HW was lower than that
determined by the MS criteria defined by the NCEP-
ATP III and IDF. Individuals with HW had a higher
prevalence of hyperglycemia and/or type-2 diabetes
compared with those without HW. They suggested that
HW is a useful indicator of CVD and type-2 diabetes in
young subjects who do not meet the criteria for MS. A
study conducted by Gazi et al. [10] has revealed that
HW screening is simple and cost-effective for detecting
metabolic abnormalities compared with the use of the
MS criteria. Blackburn et al. [30] found that Canadian
women with HW had more metabolic risk factors and a
higher BMI and WC compared with women without
HW. They suggested that HW was comparable to the
NCEP-ATP III criteria as a tool for identifying Canadian
women with cardiometabolic risk factors and coronary
artery disease.
Some studies have demonstrated that metabolic abnor-
malities are more strongly associated with the HW
phenotype than with the TG level or WC alone [3, 5, 16,
23, 27]. For example, Després et al. [27] have found that
obese subjects with HW can present with strong risk
factors for coronary heart disease even without hyper-
tension, hypercholesterolemia, or hyperglycemia. They
argued that the combined use of WC and the TG level
to identify subjects at high risk of disease might be
Table 4 Analysis of the associations and powers of models of the HW phenotype and all phenotypes consisting of an individual
index with/without the TG level to predict hyper-LDL cholesterolemia
Variable Crude Adjustment AUC Phenotype AUC
p OR (95 % CI) p OR (95 % CI) NB LR NB LR
HW phenotypea <0.0001 1.826 (1.541–2.164) <0.0001 1.459 (1.222–1.741)
TG <0.0001 1.324 (1.246–1.406) <0.0001 1.236 (1.159–1.318) 0.598 0.638
Age <0.0001 1.659 (1.525–1.805) 0.653 0.636 Age + TG 0.662 0.65
Weight <0.0001 1.231 (1.145–1.324) <0.0001 1.244 (1.154–1.341) 0.57 0.571 Weight + TG 0.603 0.629***
BMI <0.0001 1.418 (1.32–1.524) <0.0001 1.27 (1.176–1.373) 0.618 0.618 BMI + TG 0.632 0.644**
NeckC 0.0004 1.143 (1.062–1.23) 0.0004 1.157 (1.068–1.253) 0.539 0.542 NeckC + TG 0.591 0.631***
ChestC <0.0001 1.404 (1.304–1.511) <0.0001 1.325 (1.222–1.436) 0.605 0.606 ChestC + TG 0.62 0.634***
RibC <0.0001 1.389 (1.292–1.494) <0.0001 1.282 (1.179–1.393) 0.607 0.608 RibC + TG 0.622 0.635***
WaistC (WC) <0.0001 1.397 (1.297–1.505) <0.0001 1.242 (1.142–1.35) 0.609 0.606 WaistC + TG 0.623 0.634***
HipC 0.0010 1.132 (1.051–1.218) 0.0005 1.147 (1.061–1.24) 0.534 0.54 HipC + TG 0.599 0.63***
Neck_Hip 0.7273 1.013 (0.94–1.093) 0.9135 1.005 (0.925–1.091) 0.484 0.49 Neck_Hip + TG 0.593 0.636***
Axillary_Hip <0.0001 1.258 (1.168–1.355) <0.0001 1.197 (1.104–1.298) 0.57 0.572 Axillary_Hip + TG 0.6 0.623***
Chest_Hip <0.0001 1.442 (1.338–1.554) <0.0001 1.311 (1.205–1.426) 0.611 0.611 Chest_Hip + TG 0.622 0.635***
Rib_Hip <0.0001 1.438 (1.334–1.55) <0.0001 1.283 (1.17–1.405) 0.611 0.613 Rib_Hip + TG 0.622 0.636***
Waist_Hip (WHR) <0.0001 1.464 (1.358–1.579) <0.0001 1.233 (1.126–1.35) 0.613 0.614 Waist_Hip + TG 0.623 0.636***
Pelvic_Hip <0.0001 1.418 (1.311–1.533) 0.0122 1.124 (1.026–1.232) 0.595 0.597 Pelvic_Hip + TG 0.61 0.629***
Forehead_Waist <0.0001 0.652 (0.6–0.708) <0.0001 0.767 (0.698–0.843) 0.618 0.616 Forehead_Waist + TG 0.626 0.636***
Neck_Waist <0.0001 0.685 (0.632–0.743) <0.0001 0.823 (0.753-0.9) 0.604 0.603 Neck_Waist + TG 0.618 0.634***
Forehead_Rib <0.0001 0.655 (0.604–0.709) <0.0001 0.741 (0.675-0.814) 0.619 0.618 Forehead_Rib + TG 0.628 0.637***
Forehead_Chest <0.0001 0.651 (0.601–0.706) <0.0001 0.728 (0.665-0.796) 0.617 0.619 Forehead_Chest + TG 0.626 0.637***
WHtR <0.0001 1.334 (1.242–1.434) <0.0001 1.264 (1.172-1.363) 0.598 0.598 WHtR + TG 0.619 0.635***
Adjustments for age and site (investigation site), OR odds ratio, CI confidence interval, AUC area under the receiver operating characteristic curve, NB naïve Bayes,
LR logistic regression
Significant difference between a single anthropometric index and phenotype on AUCs determined by LR, ** p = <0.0001, and *** p = <0.00001
a There were 1268 women with the HW phenotype in the non-hyper-LDL cholesterolemia group (n = 6918) and 216 in the hyper-LDL cholesterolemia
group (n = 743)
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better compared with the use of WC or the TG level
alone. A seven-year longitudinal study of women has
demonstrated that WC is a better correlate of visceral
adipose tissue mass compared with the WHR. Okosuna
and Boltrib [16] found that individuals with HW were at
a higher risk of type-2 diabetes compared with those
with either hypertriglyceridemia or increased WC alone.
They determined that the association of type-2 diabetes
with HW was substantially higher in American men and
women of African descent compared with Caucasians.
Sam et al. [23] indicated that in non-Hispanic white and
non-Hispanic black subjects in Chicago, WC alone was
not predictive of a higher degree of visceral fat accumu-
lation, even in individuals with type-2 diabetes. They
found that the relationship between HW and coronary
atherosclerosis may be associated with the proathero-
genic lipoprotein changes related to HW and that the
combination of the fasting TG level and WC constituted
a simple and inexpensive tool to predict high visceral fat
mass, CVD and metabolic disease. Our findings are thus
consistent with those of these previous studies. We
found that all combinations of an anthropometric index
+ TG were more strongly predictive of the five metabolic
components than the single indices alone, with the ex-
ception of waist + TC for SBP. Combined phenotypes
that include the TG level are thus better predictors of
metabolic abnormalities compared with a single an-
thropometric index.
Our findings demonstrated that age was a stronger
predictor of the TC and LDL cholesterol levels and SBP.
Additionally, SBP was more strongly associated with age
compared with DBP. Our results are consistent with
those of previous studies [44–49]. Barbieri et al. [44]
have argued that the important indicators of SBP include
age, the severity of carotid atherosclerosis, and the insu-
lin resistance syndrome score. Wright et al. [45] have
found that age, gender, smoking, and weight are corre-
lated with SBP, whereas anxiety and weight, but not age,
are correlated with DBP. Terzolo et al. [46] have docu-
mented that age and the midnight cortisol level are asso-
ciated with SBP, but not with DBP. In a study of the
association between blood pressure and age, gender, and
Table 5 Analysis of the associations and powers of models of the HW phenotype and all phenotypes consisting of an individual
index with/without the TG level to predict SBP
Variable Crude Adjustment AUC Phenotype AUC
p OR (95 % CI) p OR (95 % CI) NB LR NB LR
HW phenotypea <0.0001 2.362 (2.029–2.749) <0.0001 1.646 (1.397–1.938)
TG <0.0001 1.377 (1.3–1.459) <0.0001 1.24 (1.165–1.321) 0.62 0.631
Age <0.0001 2.345 (2.152–2.555) 0.707 0.707 Age + TG 0.713 0.718
Weight <0.0001 1.153 (1.078–1.234) <0.0001 1.271 (1.183–1.366) 0.547 0.541 Weight + TG 0.621 0.627***
BMI <0.0001 1.483 (1.388–1.585) <0.0001 1.364 (1.267–1.468) 0.62 0.621 BMI + TG 0.644 0.649***
NeckC <0.0001 1.449 (1.356–1.548) <0.0001 1.309 (1.216–1.409) 0.616 0.616 NeckC + TG 0.641 0.648*
ChestC <0.0001 1.529 (1.428–1.637) <0.0001 1.355 (1.255–1.463) 0.627 0.627 ChestC + TG 0.645 0.65***
RibC <0.0001 1.714 (1.601–1.834) <0.0001 1.385 (1.28–1.498) 0.665 0.665 RibC + TG 0.672 0.677*
WaistC (WC) <0.0001 1.677 (1.564–1.797) <0.0001 1.334 (1.233–1.444) 0.653 0.653 WaistC + TG 0.61 0.626***
HipC <0.0001 1.178 (1.101–1.26) <0.0001 1.187 (1.104–1.278) 0.54 0.543 HipC + TG 0.623 0.637***
Neck_Hip <0.0001 1.269 (1.188–1.356) 0.0043 1.114 (1.035–1.2) 0.575 0.575 Neck_Hip + TG 0.626 0.635***
Axillary_Hip <0.0001 1.356 (1.267–1.452) <0.0001 1.211 (1.122–1.307) 0.591 0.592 Axillary_Hip + TG 0.647 0.651***
Chest_Hip <0.0001 1.563 (1.459–1.676) <0.0001 1.295 (1.196–1.402) 0.629 0.629 Chest_Hip + TG 0.647 0.651***
Rib_Hip <0.0001 1.888 (1.758–2.029) <0.0001 1.388 (1.273–1.513) 0.685 0.685 Rib_Hip + TG 0.687 0.692*
Waist_Hip (WHR) <0.0001 1.835 (1.707–1.972) <0.0001 1.327 (1.217–1.446) 0.67 0.67 Waist_Hip + TG 0.675 0.681***
Pelvic_Hip <0.0001 1.649 (1.531–1.777) <0.0001 1.25 (1.142–1.369) 0.639 0.641 Pelvic_Hip + TG 0.657 0.663***
Forehead_Waist <0.0001 0.542 (0.5–0.586) <0.0001 0.717 (0.655–0.784) 0.663 0.663 Forehead_Waist + TG 0.666 0.673***
Neck_Waist <0.0001 0.678 (0.63–0.731) 0.0007 0.866 (0.796–0.941) 0.609 0.609 Neck_Waist + TG 0.633 0.641***
Forehead_Rib <0.0001 0.519 (0.48–0.561) <0.0001 0.677 (0.619–0.742) 0.676 0.676 Forehead_Rib + TG 0.677 0.683**
Forehead_Chest <0.0001 0.602 (0.559–0.649) <0.0001 0.712 (0.654–0.776) 0.639 0.639 Forehead_Chest + TG 0.65 0.654***
WHtR <0.0001 1.318 (1.233–1.408) <0.0001 1.322 (1.23–1.421) 0.581 0.584 WHtR + TG 0.626 0.632***
Adjustments for age and site (investigation site), OR odds ratio, CI confidence interval, AUC area under the receiver operating characteristic curve, NB naïve Bayes,
LR logistic regression
Significant difference between a single anthropometric index and phenotype on AUCs determined by LR, * p = <0.01, ** p = <0.0001, and *** p = <0.00001
a There were 1182 women with the HW phenotype in the normal SBP group (n = 6756) and 302 in the high SBP group (n = 905)
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BMI and the association between BP and ECG signs in
1851 Inuits in East Greenland, Andersen et al. [47]
found that age and BMI were associated with high SBP
and that age and gender were associated with high DBP;
however, they found that age was more strongly corre-
lated with SBP than with DBP. van Stiphout et al. [48]
determined that age, weight, and the parental cholesterol
concentration were associated with the TC concentra-
tion in a population derived from two regions of the
Dutch town of Zoetermeer. Further, Berge and Nordøy
[49] argued that age was strongly associated with the TC
concentration in a study of the effects of age and meno-
pause and the associations among risk factors of CVD,
serum ferritin, and sex hormones in healthy premeno-
pausal and postmenopausal women.
Among metabolic components, such as the TC, HDL,
and LDL levels, SBP, and DBP, we found that the HW
phenotype was the least strongly associated with the
LDL level. One cause of this phenomenon may be the
weak association between the LDL level and the an-
thropometric indices compared with the other
components. For example, in a study of the correlations
between anthropometric indices and cardiometabolic
factors in Hispanics living in Puerto Rico, Palacios et al.
[50] showed that the correlations of LDL with WC,
BMI, and the WHR and waist-to-height circumference
ratio (WHtR) were lower compared with those of LDL
with HDL, SBP, DBP, and TC/HDL. In a study of an
urban population in eastern India, Prasad et al. [51]
found that LDL was very weakly associated with an-
thropometric indices, such as BMI, WC, and the WHR
and WHtR compared with the associations of SBP, DBP,
TC, or HDL with the four anthropometric indices. BMI,
WC, and the WHR and WHtR were weaker predictors
of the LDL level compared with SBP, DBP, TC, or HDL.
For increased validity, the data were analyzed using
two statistical methods, NB and LR, and the AUC values
of the indices and phenotypes obtained using these two
methods were found to be the same or similar for the
five metabolic abnormalities. For the TC level (hyper-
cholesterolemia), the differences in the AUC values be-
tween NB and LR were approximately ±0.039–0.001 for
Table 6 Analysis of the associations and powers of models of the HW phenotype and all phenotypes consisting of an individual
index with/without the TG level to predict DBP
Variable Crude Adjustment AUC Phenotype AUC
p OR (95 % CI) p OR (95 % CI) NB LR NB LR
HW phenotypea <0.0001 2.174 (1.877–2.517) <0.0001 1.946 (1.664–2.276)
TG <0.0001 1.276 (1.207–1.35) <0.0001 1.236 (1.164–1.313) 0.585 0.591
Age <0.0001 1.331 (1.242–1.426) 0.572 0.572 Age + TG 0.602 0.6*
Weight <0.0001 1.368 (1.284–1.457) <0.0001 1.425 (1.335–1.521) 0.59 0.593 Weight + TG 0.609 0.614**
BMI <0.0001 1.48 (1.389–1.577) <0.0001 1.492 (1.393–1.598) 0.618 0.618 BMI + TG 0.625 0.627
NeckC <0.0001 1.514 (1.42–1.613) <0.0001 1.387 (1.296–1.485) 0.628 0.628 NeckC + TG 0.638 0.64
ChestC <0.0001 1.56 (1.461–1.665) <0.0001 1.516 (1.411–1.629) 0.63 0.63 ChestC + TG 0.634 0.637*
RibC <0.0001 1.57 (1.472–1.674) <0.0001 1.451 (1.35–1.56) 0.637 0.637 RibC + TG 0.638 0.642
WaistC (WC) <0.0001 1.546 (1.448–1.651) <0.0001 1.459 (1.355–1.57) 0.629 0.629 WaistC + TG 0.633 0.637*
HipC <0.0001 1.377 (1.293–1.467) <0.0001 1.358 (1.27–1.451) 0.589 0.591 HipC + TG 0.61 0.615*
Neck_Hip 0.0002 1.128 (1.058–1.203) 0.5271 1.023 (0.954–1.097) 0.535 0.536 Neck_Hip + TG 0.59 0.596***
Axillary_Hip <0.0001 1.222 (1.145–1.304) <0.0001 1.183 (1.102–1.269) 0.56 0.562 Axillary_Hip + TG 0.596 0.599***
Chest_Hip <0.0001 1.344 (1.259–1.435) <0.0001 1.289 (1.196–1.389) 0.586 0.587 Chest_Hip + TG 0.606 0.607***
Rib_Hip <0.0001 1.421 (1.33–1.517) <0.0001 1.272 (1.174–1.379) 0.605 0.606 Rib_Hip + TG 0.618 0.618*
Waist_Hip (WHR) <0.0001 1.406 (1.316–1.503) <0.0001 1.31 (1.207–1.421) 0.601 0.602 Waist_Hip + TG 0.615 0.617**
Pelvic_Hip <0.0001 1.265 (1.182–1.354) <0.0001 1.208 (1.112–1.313) 0.559 0.563 Pelvic_Hip + TG 0.591 0.596***
Forehead_Waist <0.0001 0.643 (0.599–0.691) <0.0001 0.66 (0.607–0.718) 0.621 0.622 Forehead_Waist + TG 0.625 0.629*
Neck_Waist <0.0001 0.788 (0.736–0.844) <0.0001 0.814 (0.753–0.879) 0.568 0.569 Neck_Waist + TG 0.595 0.599***
Forehead_Rib <0.0001 0.629 (0.586–0.675) <0.0001 0.658 (0.606–0.715) 0.628 0.628 Forehead_Rib + TG 0.63 0.633*
Forehead_Chest <0.0001 0.648 (0.604–0.696) <0.0001 0.643 (0.593–0.696) 0.62 0.62 Forehead_Chest + TG 0.624 0.627*
WHtR <0.0001 1.44 (1.352–1.534) <0.0001 1.466 (1.373–1.567) 0.609 0.61 WHtR + TG 0.62 0.623*
Adjustments for age and site (investigation site), OR odds ratio, CI confidence interval, AUC area under the receiver operating characteristic curve, NB naïve Bayes,
LR logistic regression
Significant difference between a single anthropometric index and phenotype on AUCs determined by LR, * p = <0.01, ** p = <0.0001, and *** p = <0.00001
a There were 1163 women with the HW phenotype in the normal DBP group (n = 6644) and 321 in the high DBP group (n = 1017)
Lee et al. BMC Complementary and Alternative Medicine  (2016) 16:59 Page 9 of 12
the individual indices and approximately ±0.048–0.018
for the phenotypes. For the HDL level (hypo-HDL cho-
lesterolemia), the differences in the AUC values between
the two statistical methods were approximately the
same, with the exceptions of ±0.001 for HipC, Nec-
k_Hip, and Rib_Hip and 0.031 for TG for the individual
indices and approximately ±0.029–0.008 for the pheno-
types. For the LDL level (hyper-LDL cholesterolemia),
the differences in the AUC values were approximately
±0.04–0 for the individual indices and approximately
±0.043–0.009 for the phenotypes. The differences in the
AUC values between NB and LR were approximately
±0.01–0 for the individual indices and approximately
±0.016–0.004 for the phenotypes for SBP, and they were
approximately ±0.006–0 for both the individual indices
and phenotypes for DBP.
Finally, all individual variables were stronger predic-
tors when combined with the TG level compared with
the use of each variable alone. Thus, phenotypes can
provide better results compared with single anthropo-
metric indices in the prediction of metabolic abnormal-
ities. We think that this is a logical result because it is
well known that the TG level, which is included in the
various phenotypes in this study, is strongly associated
with MS and that it is a factor for this syndrome. Con-
sidering the limitations of the study, in the future, we
will consider associations among specific and regional
characteristics of body fat mass, TG, and MS. We exam-
ined several characteristics related to particular body lo-
cations in this study. The associations between these
specific locations and metabolic abnormalities may differ
according to age, gender, ethnic group, and country. In
addition, with regard to feature selection techniques, the
limitation of this study is that the assessment of pheno-
types according to a combination of TG and one an-
thropometric index may not be useful for improving the
prediction of metabolic abnormalities or MS. Feature se-
lection was not used in our experiments. We simply ex-
amined the combination of a single anthropometric
index and the TG level, for example, age + TG, weight +
TG, BMI + TG, etc., because the aim of this study was to
assess phenotypes consisting of one individual index and
the TG level. However, the use of such combinations
may result in the omission of important feature combi-
nations or optimal feature subsets. In addition, models
constructed using various feature selection techniques
and search strategies may achieve increased predictive
power for metabolic abnormalities or MS. For example,
a top-down strategy (backward elimination) begins with
all features and then sequentially eliminates irrelevant
features, and a bottom-up strategy (forward selection)
begins with an empty feature set or the most important
feature and iteratively adds features [52–54]. Further
study is needed to identify optimal feature subsets using
various feature selection techniques and search strategies
for the improved prediction of metabolic abnormalities
and MS.
Conclusions
A large number of studies have suggested that the HW
phenotype is strongly associated with metabolic abnor-
malities, CVD, and diabetes; however, to date, no study
has reported the predictive power of the TG level com-
bined with WC and with single anthropometric indices.
In this study, we demonstrated an association between
the HW phenotype and metabolic abnormalities, in
addition to the power of various phenotypes to predict
metabolic abnormalities in Korean women. Our findings
suggest that although the HW phenotype is the most
strongly associated with metabolic abnormalities, the
best predictive phenotypes consisting of an individual
index and the TG level may differ according to the
metabolic factors present. Phenotypes can provide better
predictive power compared with single anthropometric
indices in the identification of metabolic abnormalities.
To our knowledge, this is the first study that has
assessed the predictive power of phenotypes consisting
of the TG level and individual anthropometric indices to
identify subjects with metabolic abnormalities.
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